Race Oncology

Three ASX biotech shares—Race Oncology, Inoviq, and Lumos Diagnostics—surged due to promising updates: Race Oncology submitted ethics for a cancer trial, Inoviq completed breast cancer specificity testing, and Lumos Diagnostics received US reimbursement for its FebriDx test.

The article discusses the implementation of a Server-Side Rendering (SSR) service entry in a web application, focusing on the configuration and hidden attributes associated with the SSR process.